170 related articles for article (PubMed ID: 34026778)
1. Vagus Nerve Stimulation: A Potential Adjunct Therapy for COVID-19.
Azabou E; Bao G; Bounab R; Heming N; Annane D
Front Med (Lausanne); 2021; 8():625836. PubMed ID: 34026778
[TBL] [Abstract][Full Text] [Related]
2. Targeting the cholinergic anti-inflammatory pathway with vagus nerve stimulation in patients with Covid-19?
Bonaz B; Sinniger V; Pellissier S
Bioelectron Med; 2020; 6():15. PubMed ID: 32743022
[TBL] [Abstract][Full Text] [Related]
3. Activation of the Cholinergic Anti-Inflammatory Pathway as a Novel Therapeutic Strategy for COVID-19.
Qin Z; Xiang K; Su DF; Sun Y; Liu X
Front Immunol; 2020; 11():595342. PubMed ID: 33633726
[TBL] [Abstract][Full Text] [Related]
4. Selective Vagus Nerve Stimulation as a Therapeutic Approach for the Treatment of ARDS: A Rationale for Neuro-Immunomodulation in COVID-19 Disease.
Mastitskaya S; Thompson N; Holder D
Front Neurosci; 2021; 15():667036. PubMed ID: 33927594
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
7. Neuromodulation Strategies to Reduce Inflammation and Improve Lung Complications in COVID-19 Patients.
Czura CJ; Bikson M; Charvet L; Chen JDZ; Franke M; Fudim M; Grigsby E; Hamner S; Huston JM; Khodaparast N; Krames E; Simon BJ; Staats P; Vonck K
Front Neurol; 2022; 13():897124. PubMed ID: 35911909
[TBL] [Abstract][Full Text] [Related]
8. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory Effects of Abdominal Vagus Nerve Stimulation on Experimental Intestinal Inflammation.
Payne SC; Furness JB; Burns O; Sedo A; Hyakumura T; Shepherd RK; Fallon JB
Front Neurosci; 2019; 13():418. PubMed ID: 31133776
[TBL] [Abstract][Full Text] [Related]
10. Short-term transcutaneous non-invasive vagus nerve stimulation may reduce disease activity and pro-inflammatory cytokines in rheumatoid arthritis: results of a pilot study.
Drewes AM; Brock C; Rasmussen SE; Møller HJ; Brock B; Deleuran BW; Farmer AD; Pfeiffer-Jensen M
Scand J Rheumatol; 2021 Jan; 50(1):20-27. PubMed ID: 33047630
[No Abstract] [Full Text] [Related]
11. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive Auricular Vagus Nerve Stimulation as a Potential Treatment for Covid19-Originated Acute Respiratory Distress Syndrome.
Kaniusas E; Szeles JC; Kampusch S; Alfageme-Lopez N; Yucuma-Conde D; Li X; Mayol J; Neumayer C; Papa M; Panetsos F
Front Physiol; 2020; 11():890. PubMed ID: 32848845
[No Abstract] [Full Text] [Related]
13. Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19.
Dalamaga M; Karampela I; Mantzoros CS
Metabolism; 2020 Aug; 109():154282. PubMed ID: 32497535
[TBL] [Abstract][Full Text] [Related]
14. Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology.
Yokota S; Miyamae T; Kuroiwa Y; Nishioka K
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33671159
[TBL] [Abstract][Full Text] [Related]
15. COVID-19: general overview, pharmacological options and ventilatory support strategies.
Menzella F; Matucci A; Vultaggio A; Barbieri C; Biava M; Scelfo C; Fontana M; Facciolongo NC
Multidiscip Respir Med; 2020 Jan; 15(1):708. PubMed ID: 33282284
[TBL] [Abstract][Full Text] [Related]
16. Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm.
Desjarlais M; Wirth M; Lahaie I; Ruknudin P; Hardy P; Rivard A; Chemtob S
Front Pharmacol; 2020; 11():602999. PubMed ID: 33362557
[TBL] [Abstract][Full Text] [Related]
17. Can neuromodulation support the fight against the COVID19 pandemic? Transcutaneous non-invasive vagal nerve stimulation as a potential targeted treatment of fulminant acute respiratory distress syndrome.
Bara GA; de Ridder D; Maciaczyk J
Med Hypotheses; 2020 Oct; 143():110093. PubMed ID: 33017913
[TBL] [Abstract][Full Text] [Related]
18. Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the
López-Iranzo FJ; López-Rodas AM; Franco L; López-Rodas G
Curr Pharm Des; 2020; 26(35):4515-4521. PubMed ID: 32787748
[TBL] [Abstract][Full Text] [Related]
19. The Vagal Autonomic Pathway of COVID-19 at the Crossroad of Alzheimer's Disease and Aging: A Review of Knowledge.
Rangon CM; Krantic S; Moyse E; Fougère B
J Alzheimers Dis Rep; 2020 Dec; 4(1):537-551. PubMed ID: 33532701
[TBL] [Abstract][Full Text] [Related]
20. Potential value of neuroimmunotherapy for COVID-19: efficacies and mechanisms of vagus nerve stimulation, electroacupuncture, and cholinergic drugs.
Yu X; Kong Q
Front Immunol; 2023; 14():1197467. PubMed ID: 37475861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
